









Markets
/
Stocks
/
nasdaq-vrex
/

Varex Imaging Corp

VREX

11.970USD

+0.080+0.67%

Close 11/07, 16:00（ET）Quotes delayed by 15 min

497.00MMarket Cap

LossP/E TTM



Varex Imaging Corp

11.970

+0.080+0.67%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Varex Imaging Corp

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Varex Imaging Corp's Score

Industry at a Glance

Industry Ranking

22 / 209

Overall Ranking

74 / 4614

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 5 analysts

Buy

Current Rating

17.800

Target Price

+48.71%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Varex Imaging Corp Highlights

StrengthsRisks

Varex Imaging Corporation is a designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD .

Undervalued

The company’s latest PE is -3.71, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 39.01M shares, decreasing 14.68% quarter-over-quarter.

Held by Richard Pzena

Star Investor Richard Pzena holds 4.24M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.10.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.77, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 203.00M, representing a year-over-year decrease of 2.92%, while its net profit experienced a year-over-year decrease of 6464.29%.

Score

Industry at a Glance

Previous score

7.77

Change



Financials

7.94

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.20

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.12

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.20

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.36

Key Metrics

Free cash flow

No Data

Varex Imaging Corp's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 8.19, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -3.71, which is -976.01% below the recent high of 32.53 and -284.17% above the recent low of -14.27.

Score

Industry at a Glance

Previous score

8.19

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 22/209

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 8.40, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Varex Imaging Corp is 16.00, with a high of 23.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.40

Change

Support & Resistance

No Data

Analyst Rating

Based on 5 analysts

Buy

Current Rating

17.800

Target Price

+48.71%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Varex Imaging Corp

VREX

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 8.65, which is higher than the Healthcare Equipment & Supplies industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 12.86 and the support level at 10.96, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.36

Change

1.29

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(5)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.017

Neutral

RSI(14)

53.634

Neutral

STOCH(KDJ)(9,3,3)

40.503

Neutral

ATR(14)

0.491

Low Volatility

CCI(14)

28.762

Neutral

Williams %R

48.147

Neutral

TRIX(12,20)

0.088

Sell

StochRSI(14)

70.166

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

11.912

Buy

MA10

11.950

Buy

MA20

11.799

Buy

MA50

11.766

Buy

MA100

10.288

Buy

MA200

10.343

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.42. The latest institutional shareholding proportion is 94.00%, representing a quarter-over-quarter decrease of 5.39%. The largest institutional shareholder is Richard Pzena, holding a total of 4.24M shares, representing 10.23% of shares outstanding, with 10.58% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Pzena Investment Management, LLC

Star Investors

4.24M

+11.64%

BlackRock Institutional Trust Company, N.A.

3.21M

-4.35%

The Vanguard Group, Inc.

Star Investors

2.82M

+8.20%

Allspring Global Investments, LLC

2.79M

+0.31%

Dimensional Fund Advisors, L.P.

2.13M

-0.42%

Cooke & Bieler, L.P.

2.14M

+0.67%

Neuberger Berman, LLC

1.50M

+22.79%

Frontier Capital Management Company, LLC

1.27M

-7.94%

State Street Investment Management (US)

1.06M

-39.76%

Geode Capital Management, L.L.C.

989.06K

+2.73%

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 4.99, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.85. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.